Please login to the form below

Not currently logged in


This page shows the latest eTheRNA news and features for those working in and with pharma, biotech and healthcare.

AbbVie suspends Kaletra patent rights as COVID-19 drug trials advance

AbbVie suspends Kaletra patent rights as COVID-19 drug trials advance

Nevertheless, biotech company eTheRNA has launched the development of a cross-strain protective coronavirus vaccine for high-risk populations. ... Viral variation means traditional medicinal and preventive vaccine approaches may fall short when

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Latest appointments

  • New hires at Crescendo, Healx and Galecto New hires at Crescendo, Healx and Galecto

    He joins Galecto from eTheRNA immunotherapies, a Belgian mRNA immunotherapy company. ... Prior to eTheRNA, Lindmark served as global VP of clinical development for the respiratory and inflammation franchises at AstraZeneca.

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs


Add my company

ROAD is a digital PR and communications consultancy specialising in promoting the innovators that shape our future health and wellbeing....

Latest intelligence

InSite Events™ National Pharma Meeting: A Customer Story
How our client leveraged Impetus Digital’s white-glove service, 360° coverage and care, and award-winning InSite Events™ platform to successfully transfer their annual national meeting online....
Fear or encouragement, which is best to drive behaviour change?
The communications industry depends on fear of the perceived loss of something, in order to create the hope found in a product benefit. But, if if left too long unchecked,...
The unheard, unseen, and uncorrected effects of COVID-19
The disproportionate effects of the pandemic have been highlighted amongst ethnic minorities, so is it likely that ethnic minorities will be more worried about participating? And could this exacerbate inequalities...